Amalia M. Issa, M.P.H., Ph. D., is the director of the Program in Personalized Medicine and Targeted Therapeutics at the Abramson Center for the Future of Health (a joint initiative of The Methodist Hospital Research Institute and the University of Houston) and associate professor at the University of Houston. She is a pharmacologist and clinical epidemiologist with primary interests in how basic and clinical pharmaceutical sciences are translated into clinical research and practice and health policy.
Dr. Issa received her doctorate from the Department of Neurology and Neurosurgery (specialization: neuropharmacology) at McGill University in Montreal, Canada, and her public health degree from the UCLA School of Public Health. She completed fellowships at Harvard Medical School and the Massachusetts General Hospital.